Gata3 immunohistochemical staining is a useful marker for metastatic breast carcinoma in fine needle aspiration specimens

Gata3 immunohistochemical staining is a useful marker for metastatic breast carcinoma in fine needle aspiration specimens

Blog Article

Aims: The utility of GATA3 immunohistochemistry (IHC) as an aid to the cytological diagnosis of metastatic breast carcinoma in VALERICALM fine needle aspiration (FNA) specimens was investigated.Materials and Methods: Cell block sections from 111 FNA cases of metastatic malignancy were stained for GATA3, including metastases from 43 breast and 44 nonmammary adenocarcinomas, 19 melanomas, 4 urothelial carcinomas, and 1 thyroid medullary carcinoma.Sites sampled included lymph nodes (87), bone (8), liver (5), lung (6), superficial masses (4), and pelvic mass (1).

Results: Ninety-one percent (39/43) of metastatic breast carcinoma cases were positive for GATA3.All estrogen receptor (ER)-positive were also GATA3 positive cases.The majority (9/14; 64%) of ER-negative and 37% (3/8) of triple-negative cases were positive for GATA3.

All nonmammary adenocarcinoma cases were negative with the exception of one case of metastatic pancreatic adenocarcinoma.Metastatic melanoma CIRCULATORY SUPPORT cases were all negative but 75% (3/4) urothelial carcinomas expressed GATA3.Conclusions: GATA3 IHC staining is a useful addition to IHC panels for FNA samples in specific settings such as distinguishing metastatic breast from lung carcinoma or melanoma.